Pharma Stocks
-
Telomir Pharma Reports Telomir-1 Kills Human Leukemia Cells
Telomir Pharmaceuticals (NASDAQ:TELO) on November 21, 2025 announced in vitro data showing its investigational small molecule Telomir-1 produced a clear,…
Read More » -
Luye Pharma Announces USD150 Million Exchangeable Shares Issuance
TipRanks Black Friday Sale An announcement from Luye Pharma Group ( (HK:2186) ) is now available. Luye Pharma Group announced…
Read More » -
Here’s Why We Think AFT Pharmaceuticals (NZSE:AFT) Is Well Worth Watching
It’s common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even…
Read More » -
A Look at Agios Pharmaceuticals’s Valuation After Mixed Results From RISE UP Mitapivat Trial (AGIO)
Agios Pharmaceuticals (AGIO) released results from its Phase 3 RISE UP study for mitapivat in sickle cell disease. The trial…
Read More » -
Takeda Pharmaceutical (TSE:4502): Exploring Valuation as Shares Show Renewed Momentum
Takeda Pharmaceutical (TSE:4502) shares have shown solid momentum recently, gaining around 1% in the past day and 4% over the…
Read More » -
Can Stevanato Group’s (STVN) Steady Guidance Sustain Investor Confidence Amid Industry Shifts?
Stevanato Group S.p.A. recently announced its third quarter and nine-month 2025 results, highlighting sales of €303.17 million and net income…
Read More » -
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
The Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) share price has done very well over the last month, posting an excellent gain of…
Read More » -
Why Is Agios Pharmaceuticals Stock Sinking Today? – Agios Pharmaceuticals (NASDAQ:AGIO)
Agios Pharmaceuticals Inc. (NASDAQ:AGIO) stock plunged on Wednesday after the company released topline results from RISE UP Phase 3 data…
Read More » -
Nxera Introduces Employee Stock Ownership Plan (J-ESOP) for
Tokyo, Japan and Cambridge, UK, 19 November 2025 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) announces…
Read More » -
Earnings Troubles May Signal Larger Issues for Orchid Pharma (NSE:ORCHPHARMA) Shareholders
Last week’s earnings announcement from Orchid Pharma Limited (NSE:ORCHPHARMA) was disappointing to investors, with a sluggish profit figure. Our analysis…
Read More »